Long-term Study of DSP-5423P in Patients With Schizophrenia

Long-term Study of DSP-5423P in Patients With Schizophrenia <Phase 3>

The study evaluates the long term safety of DSP-5423P in patients with schizophrenia.

Inclusion Criteria:

• Patients who have schizophrenia diagnosed by DSM-5, diagnostic criteria
• Patients who are aged 18 years or older at informed consent
• Patient understands the objectives and procedures of the study and who provide written voluntarily consent to participate in the study, etc.

Exclusion Criteria:

• Patients who fall under a contraindication listed in the LONASEN® package insert
• Patients with Parkinson disease, etc.